127 related articles for article (PubMed ID: 12362634)
1. [Morphofunctional characteristics of erythrocytes in extracorporeal efferent detoxication].
Samoĭlov MV; Mishnev OD; Kudriavtsev IuV; Naumov AG; Danilkov AP
Klin Lab Diagn; 2002 Aug; (8):19-23. PubMed ID: 12362634
[TBL] [Abstract][Full Text] [Related]
2. [Transformed and pathological red cells in endogenous intoxication and extracorporeal detoxication].
Samoĭlov MV; Mishnev OD; Kudriavtsev IuV
Arkh Patol; 2002; 64(5):36-40. PubMed ID: 12575540
[TBL] [Abstract][Full Text] [Related]
3. [Morphofunctional characteristics of erythrocytes in chronic kidney failure and purulent intoxication].
Samoĭlov MV; Mishnev OD; Kudriavtsev IuV; Naumov AG; Danilkov AP
Klin Lab Diagn; 2002 Jun; (6):18-23. PubMed ID: 12132370
[TBL] [Abstract][Full Text] [Related]
4. Superoxide anion generation, erythrocytes superoxide dismutase activity, and lipid peroxidation during hemoperfusion and hemodialysis in chronic uremic patients.
Trznadel K; Pawlicki L; Kedziora J; Luciak M; Błaszczyk J; Buczyński A
Free Radic Biol Med; 1989; 6(4):393-7. PubMed ID: 2540072
[TBL] [Abstract][Full Text] [Related]
5. Rheological properties of red blood cells (including reticulocytes) in patients with chronic renal disease.
Nowak E; Wyrwicz G; Dabrowski Z; Smoleńiski O; Spodaryk K
Clin Hemorheol Microcirc; 1999; 21(2):87-94. PubMed ID: 10599591
[TBL] [Abstract][Full Text] [Related]
6. [Blood viscosity and the erythrocyte charge in patients with chronic kidney failure and suppurative intoxication and during the correction of these conditions by hemosorption and hemodialysis].
Samoĭlov MV; Zakharchenko VN; Larionov SM; Naumov AG; Danilkov AP; Zakharova VD; Ivleva AI; Kudriavtsev IuV; Surikova TP
Urol Nefrol (Mosk); 1993; (4):34-7. PubMed ID: 8310565
[TBL] [Abstract][Full Text] [Related]
7. [The morphological characteristics of the erythrocytes during hemosorption in patients with chronic kidney failure and suppurative intoxication].
Samoĭlov MV; Danilkov AP; Kudriavtsev IuV; Naumov AG
Urol Nefrol (Mosk); 1993; (1):34-7. PubMed ID: 7941124
[TBL] [Abstract][Full Text] [Related]
8. SEM studies of erythrocyte shape as an indicator of erythrocyte function.
Dardano JR; Kimzey SL
Scan Electron Microsc; 1979; (3):809-14, 800. PubMed ID: 524049
[No Abstract] [Full Text] [Related]
9. [Hemosorption as a treatment method for uremic complications].
Pilotovich VS; Ostapenko VA; Shilaĭ LM; Kirkovskiĭ VV; Nikolaĭchik VV
Klin Med (Mosk); 1982 Apr; 60(4):77-80. PubMed ID: 7098397
[No Abstract] [Full Text] [Related]
10. First clinical experience with an adjunctive hemoperfusion device designed specifically to remove beta(2)-microglobulin in hemodialysis.
Ronco C; Brendolan A; Winchester JF; Golds E; Clemmer J; Polaschegg HD; Muller TE; La Greca G ; Levin NW
Blood Purif; 2001; 19(2):260-3. PubMed ID: 11150821
[No Abstract] [Full Text] [Related]
11. [Disordered lipid metabolism and the morphofunctional instability of the erythrocyte membranes in patients with terminal kidney failure].
Grinshteĭn IuI; Tereshchenko VP; Tereshchenko IuA; Romanova VIa
Ter Arkh; 1990; 62(6):84-8. PubMed ID: 2218935
[TBL] [Abstract][Full Text] [Related]
12. Adsorption of Protein-Bound Uremic Toxins Through Direct Hemoperfusion With Hexadecyl-Immobilized Cellulose Beads in Patients Undergoing Hemodialysis.
Yamamoto S; Sato M; Sato Y; Wakamatsu T; Takahashi Y; Iguchi A; Omori K; Suzuki Y; Ei I; Kaneko Y; Goto S; Kazama JJ; Gejyo F; Narita I
Artif Organs; 2018 Jan; 42(1):88-93. PubMed ID: 28703401
[TBL] [Abstract][Full Text] [Related]
13. The Case | Rapidly progressing polyneuropathy in a dialysis patient.
Chen T; Cleland B; Nankivell BJ
Kidney Int; 2016 Jun; 89(6):1409-10. PubMed ID: 27181789
[No Abstract] [Full Text] [Related]
14. Effect of hemodialysis on lipid peroxidation and antioxidant system in patients with chronic renal failure.
Mohora M; Mircescu G; Cîrjan C; Mihăilescu I; Gîrneaţă L; Ursea N; Dinu V
Rom J Intern Med; 1995; 33(3-4):237-42. PubMed ID: 8646196
[TBL] [Abstract][Full Text] [Related]
15. [Comparative characteristics of hemostasis system in patients with endstage renal disease admitted for urgent and elective hemodialysis].
Kotliarova GV; Kozlovskaia NL; Lashutin SV; Komiagin IuV; Shakhnova EA; Dobromyslov IA; Shilov EM; Nesterova SG
Ter Arkh; 2011; 83(6):36-41. PubMed ID: 21786574
[TBL] [Abstract][Full Text] [Related]
16. Do erythrocyte sedimentation rate and C-reactive protein levels have diagnostic usefulness in patients with renal failure?
Arik N; Bedir A; Günaydin M; Adam B; Halefi I
Nephron; 2000 Oct; 86(2):224. PubMed ID: 11015011
[No Abstract] [Full Text] [Related]
17. Effect of haemodialysate and its peptide fractions on acetylcholinesterase activity in erythrocytes from healthy subjects and patients with terminal renal failure.
Smoleński O; Tabarowski Z; Miszta H; Dabrowski Z
Int Urol Nephrol; 1993; 25(5):503-8. PubMed ID: 8270380
[TBL] [Abstract][Full Text] [Related]
18. Middle-sized ninhydrin-positive molecules in uraemic patients treated by repeated haemodialysis. I. Preliminary characteristics.
Hanicki Z; Sarnecka-Keller M; Klein A; Slizowska K
Clin Chim Acta; 1974 Jul; 54(1):47-54. PubMed ID: 4847123
[No Abstract] [Full Text] [Related]
19. [Middle molecules and the problem of endogenous intoxication in critical states of various etiologies].
Vladyka AS; Levitskiĭ ER; Poddubnaia LP; Gabriélian NI
Anesteziol Reanimatol; 1987; (2):37-42. PubMed ID: 3300433
[No Abstract] [Full Text] [Related]
20. Erythrocyte Na,K pump in uremia. Acute correction of a transport defect by hemodialysis.
Izumo H; Izumo S; DeLuise M; Flier JS
J Clin Invest; 1984 Aug; 74(2):581-8. PubMed ID: 6086716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
